Labshake search
Citations for TargetMol :
1 - 25 of 25 citations for Recombinant Mouse Angiotensinogen serpin peptidase inhibitor clade A member 8 His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2021Quote: ... a 10% CCK-8 solution (Targetmol, C0005) in medium was added and re-incubated for 2 h ...
-
bioRxiv - Cell Biology 2023Quote: The kinase inhibitors inhibitor library was purchased form TargetMol (L1600, TargetMol). For drug screen ...
-
bioRxiv - Cancer Biology 2023Quote: ... protease inhibitor cocktail (TargetMol)] and were lysed by sonication for 2 hours at 4°C ...
-
bioRxiv - Microbiology 2023Quote: ... nirmatrelvir (cat. T9351, CAS No. 2628280-40-8) from Targetmol.
-
bioRxiv - Cancer Biology 2022Quote: ... The GSK3 inhibitor CHIR-99021 (TargetMol, T2310) and the tankyrase inhibitor XAV-939 (TargetMol ...
-
bioRxiv - Cell Biology 2023Quote: The Epigenetic Inhibitor library (Targetmol, cat L1200), containing 773 compounds at 10 mM ...
-
bioRxiv - Biophysics 2023Quote: ... and EDTA-free protease inhibitor cocktail (TargetMol) and lysed by dounce ...
-
bioRxiv - Cancer Biology 2022Quote: ... and the tankyrase inhibitor XAV-939 (TargetMol, T1878) were used at 10 µM final concentration ...
-
bioRxiv - Systems Biology 2022Quote: ... AKT1-2 inhibitor MK-2206 (Targetmol, 1032350-13-2), and everolimus (Targetmol ...
-
bioRxiv - Molecular Biology 2023Quote: ... and supplemented with EDTA-free protease inhibitor cocktail (TargetMol). For ET-1-ETAR-Gq/ IRL1620-ETBR-Gi complex ...
-
bioRxiv - Microbiology 2020Quote: ... Other protease inhibitors in table below were purchased from TargetMol.
-
bioRxiv - Molecular Biology 2023Quote: ... 1x protease inhibitor cocktail (TargetMol, 1 mL/100 mL suspension), 10 μM MCH and 10 μg/mL Nb35(only for MCHR2) ...
-
bioRxiv - Cancer Biology 2024Quote: ... A custom library of kinase inhibitors was purchased from TargetMol. Cell counts for long term viability assays were carried using CellDrop (Denovix ...
-
bioRxiv - Biophysics 2021Quote: ... supplemented with Protease Inhibitor Cocktail (TargetMol, 1 mL/ 100 mL suspension). ScFv16 was applied to stabilize GHRP-6–ghrelin receptor–Gq complex ...
-
bioRxiv - Biochemistry 2022Quote: ... supplemented with Protease Inhibitor Cocktail (TargetMol, 1 mL/100 mL suspension). The lysate was incubated for 1 h at room temperature and complex from membranes solubilized by 0.5% (w/v ...
-
bioRxiv - Cancer Biology 2023Quote: ... 1% NP-40) supplemented with 1% protease inhibitor cocktail (C0001, TargetMol). Immunoprecipitation was performed using Anti-FLAG M2 Magnetic Beads (M8823 ...
-
bioRxiv - Biochemistry 2023Quote: ... supplemented with Protease Inhibitor Cocktail (TargetMol, 1 mL/100 mL suspension). The lysate was incubated for 1 h at room temperature and then solubilized by 0.5% (w/v ...
-
bioRxiv - Genomics 2023Quote: ... 1/100 volume of protease inhibitor cocktail (C0001, TargetMol, Boston, USA), 0.15% Triton X-100) ...
-
bioRxiv - Biophysics 2021Quote: ... and 10 mM CaCl2 supplemented with EDTA-free protease inhibitor cocktail (TargetMol). CCKAR–G protein complexes were assembled at room temperature (RT ...
-
bioRxiv - Immunology 2023Quote: ... 10 μM CXCL12 with 100 × concentrated EDTA-free protease inhibitor cocktail (TargetMol). Subsequently ...
-
bioRxiv - Molecular Biology 2023Quote: Cell counting kit 8 (CCK8) experiment for cell viability assay were performed using the CCK8 Kit (TargetMol, MA, USA). After a treatment ...
-
bioRxiv - Cancer Biology 2024Quote: Cells were seeded into 96-well culture plates at the density of 3000 cells per well after transfected with siRNA oligos and cultured for 5 days with the viability measured daily using the Cell Counting Kit-8 (CCK8) (TargetMol) according to the manufacturer’s protocol ...
-
bioRxiv - Biophysics 2021Quote: ... 1mM dithiothreitol (DTT) and 1×ethylene diamine tetraacetic acid (EDTA) free protease inhibitor cocktail (TargetMol). The suspension was frozen in liquid nitrogen and stored at −80°C for further use.
-
bioRxiv - Immunology 2023Quote: ... CD4+ T cells were treated with a panel of 28 kinase inhibitors (SYN-2103; SYNkinase, Victoria, Australia & TargetMol, Massachusetts, USA) at the stipulated concentrations (Table S5 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 20-24 mice whose tumor volume had reached ∼250 mm3 (mouse grafts) or ∼80 mm3 (human grafts) at week two after grafting received either 10 mg/kg enzalutamide (TargetMol T6002) or 0.5% DMSO (MilliporeSigma D2650 ...